Ottawa Allergy Research Corp

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Atopic dermatitis (eczema)1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Eli Lilly and Company1 trial
• Upstream Bio Inc.1 trial

Closed trials

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Upstream Bio Inc.· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source